You are here: Industry Insights > GE

News List

GE to divest its Biopharma business to Danaher for $21.4bn pharmaceutical-technology
February 27, 2019
US-based conglomerate General Electric (GE) has entered into a definitive agreement to divest its Biopharma business to science and technology innovator Danaher for approximately $21.4bn.
GE Healthcare files confidential IPO listing: report fiercebiotech
December 25, 2018
General Electric has submitted a confidential filing to spin out its healthcare business into a publicly traded company, with an IPO likely taking place early next year, according to a report from Bloomberg....
Lonza to Establish Strategic Biomanufacturing Base in China Using GE Healthcare Solution americanpharmaceuticalreview
December 11, 2018
Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger....
BeiGene picks GE’s facility to boost cancer drugs production capacity biospectrumasia
September 19, 2018
BeiGene to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies
GE Healthcare to become independent company pharmaceutical-technology
June 28, 2018
General Electric (GE) has revealed plans to spin off its healthcare business into a standalone entity as part of its strategic restructuring to substantially mitigate debt.
GE introduces Biacore 8K+ contractpharma
June 19, 2018
GE Healthcare Life Sciences has introduced Biacore 8K+, an eight-needle high-sensitivity surface plasmon resonance (SPR) system that is able to automate over 4500 drug candidate–disease target binding experiments in one run.
GE provides FlexFactory platform to Xiangxue Pharmaceutical pharmaceutical-technology
June 13, 2018
GE Healthcare has agreed to supply its FlexFactory manufacturing platform to China-based Xiangxue Pharmaceutical for high-affinity and high-specificity T cell receptor (TCR) cell immunotherapy drugs.
GE Increases Cell Culture Media Production contractpharma
May 22, 2018
GE Healthcare Life Sciences is increasing the annual production capacity of powdered cell culture media by tenfold in its facility in Pasching, Austria.
GE Healthcare Korea to foster biotech biospectrumasia
April 17, 2018
The aim is to advance Korea’s biotech industry.
United BioPharma Inc. selects GE Healthcare’s FlexFactory manufacturing platform biospectrumasia
April 26, 2017
United BioPharma’s FlexFactory supports a rich pipeline of innovative protein drugs including UB-421, an entry inhibitor monoclonal antibody for HIV treatment

Previous page 1 2 Next page